FindTrial
Sign In

â??Study of sequential antibody estimation post COVID-19 vaccination amongst health care workersâ??

â??Study of sequential antibody estimation post COVID-19 vaccination amongst health care workersâ??

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/03/031617
Enrollment
70
Registered
2021-03-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Janakpuri Super Speciality Hospital Society
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: HCWs of JSSHS, irrespective of age and gender who has received COVID-19 vaccination.

Exclusion criteria

Exclusion criteria: • Any contradiction to venipuncture

Design outcomes

Primary

MeasureTime frame
Expected outcome: 1. Effectivity of vaccine estimated by post vaccination seropositivity rate. 2. The duration of persistance of antibodies post vaccination will be aasessed during the stipulated study period. 3. Will be able to compare antibody detection in people previously infected and non infected with SARS-CoV2Timepoint: 1. Post vaccination seropositivity rate more than 70% 2. Duration of persistence of antibodies more than 3 months—

Secondary

MeasureTime frame
1.Assist in further development of COVID-19 vaccination. 2. Ascertain need of booster dose if any. Timepoint: 1. Seropositivity assessed at 6 wks ie 14 days afer the second dose of vaccination. 2. Estimation of antibodies at 2 wks, 4 wks, 6 wks, 3 months, 6 months and 9 months post vaccination.—

Countries

India

Contacts

Public ContactPriyanka Banerjee

Janakpuri Super Speciality Hospital Society

banerjepriyanka@gmail.com09958671066

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026